Literature DB >> 11584253

Efficacy of surveillance in nosocomial infection control in a surgical service.

M Delgado-Rodríguez1, A Gómez-Ortega, M Sillero-Arenas, G Martínez-Gallego, M Medina-Cuadros, J Llorca.   

Abstract

OBJECTIVE: The purpose of this study was to assess the efficacy of surveillance of nosocomial infection in infection control at a service of general surgery.
DESIGN: A surveillance study that included 1483 patients with a prospective identification of nosocomial infection was carried out. Its results were discussed with the staff, and a program on nosocomial infection control was implemented. One year after the pre-intervention study, a similar study that included 1506 patients was done. The main outcome measure was nosocomial infection. Incidence rates, incidence rate ratios, crude and multiple-risk factor adjusted for by Poisson regression analysis, and their 95% confidence interval rates were estimated.
RESULTS: The characteristics of the patients enrolled in both studies were compared. After the intervention, the trend was to attend patients with more severe conditions: higher frequency of liver failure, chronic obstructive lung disease, higher proportion of dirty surgical wounds, and higher scores of both Study on the Efficacy of Nosocomial Infection Control (SENIC) and National Nosocomial Infections Surveillance indices. There were no significant differences in emergency surgery, duration of surgery, age, and sex. After the intervention, unnecessary chemoprophylaxis was drastically reduced, and a significant reduction in preoperative stay was observed. The nosocomial incidence rate fell from 18.4 to 14 per 1000 patient-days. This reduction yielded an incidence rate ratio of 0.56 (95% confidence interval, 0.43%-0.74%) adjusted for several variables (SENIC index, serum creatinine level, serum albumin level, antihistamine H2 level, surgical wound, body mass index, chemoprophylaxis, and community-acquired infection). Significant reductions in surgical site infection and urinary tract infection were observed, but the rate of respiratory tract infection remained unchanged.
CONCLUSIONS: Surveillance was effective in reducing nosocomial infection.

Entities:  

Mesh:

Year:  2001        PMID: 11584253     DOI: 10.1067/mic.2001.114625

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  6 in total

1.  Implementing a standard protocol to decrease the incidence of surgical site infections in rectal cancer surgery.

Authors:  Minako Kobayashi; Yasuhiro Inoue; Yasuhiko Mohri; Chikao Miki; Masato Kusunoki
Journal:  Surg Today       Date:  2010-03-26       Impact factor: 2.549

Review 2.  Safety in the operating theatre--a transition to systems-based care.

Authors:  Thomas G Weiser; Michael P Porter; Ronald V Maier
Journal:  Nat Rev Urol       Date:  2013-02-19       Impact factor: 14.432

Review 3.  Data use and effectiveness in electronic surveillance of healthcare associated infections in the 21st century: a systematic review.

Authors:  Jeroen S de Bruin; Walter Seeling; Christian Schuh
Journal:  J Am Med Inform Assoc       Date:  2014-01-13       Impact factor: 4.497

4.  Effectiveness of an automated surveillance system for intensive care unit-acquired infections.

Authors:  Jeroen S de Bruin; Klaus-Peter Adlassnig; Alexander Blacky; Harald Mandl; Karsten Fehre; Walter Koller
Journal:  J Am Med Inform Assoc       Date:  2012-08-07       Impact factor: 4.497

5.  Perioperative glycemic status is linked to postoperative complications in non-intensive care unit patients with type-2 diabetes: a retrospective study.

Authors:  Takeshi Oba; Mototsugu Nagao; Shunsuke Kobayashi; Yuji Yamaguchi; Tomoko Nagamine; Kyoko Tanimura-Inagaki; Izumi Fukuda; Hitoshi Sugihara
Journal:  Ther Adv Endocrinol Metab       Date:  2022-05-19       Impact factor: 4.435

6.  Eliminating Healthcare-Associated Infections in Iran: A Qualitative Study to Explore Stakeholders' Views.

Authors:  Atefeh Esfandiari; Hedayat Salari; Arash Rashidian; Hossein Masoumi Asl; Abbas Rahimi Foroushani; Ali Akbari Sari
Journal:  Int J Health Policy Manag       Date:  2018-01-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.